We are live on !
Find out more
Processa Pharmaceuticals
PCSA
PCSA
1.86
USD
+0.02
1.09%
At close
Updated
Nov 13, 4:00 PM EST
Pre-market
After hours
1 day
1.09%
5 days
1.64%
1 month
5.08%
3 months
-25.6%
6 months
-27.06%
Year to date
-36.52%
1 year
-74.52%
5 years
-99.94%
10 years
-99.91%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
1
Solas Capital Management
Darien,
Connecticut
| $2.97M | +$2.5M | +900 | New |
|
| 2 |
2
Millennium Management
New York
| $705K | +$594K | +214 | New |
|
| 3 |
3
Essex Investment Management
Boston,
Massachusetts
| $494K | +$416K | +150 | New |
|
| 4 |
4
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $437K | +$369K | +133 | New |
|
| 5 |
5
MYDA Advisors
Woodmere,
New York
| $265K | +$222K | +80 | New |
|
| 6 |
6
Vanguard Group
Malvern,
Pennsylvania
| $189K | +$158K | +57 | New |
|
| 7 |
7
Tower Research Capital (TRC)
New York
| $9K | +$8.33K | +3 | New |
|
| 8 |
8
Evoke Wealth
Los Angeles,
California
| $1K | – | – | – |
|